Product Code: iDATA_USCS20_MS
Throughout this medical market research, iData Research analyzed 43 cardiac surgery companies companies in the US and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the US Cardiac Surgery Device and Heart Valve Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
- 1. Procedure Volumes for the US Cardiac Surgery Market - MedPro
- 2. Tissue Heart Valve Market - MedCore
- 3. Mechanical Heart Valve Market - MedCore
- 4. Annuloplasty Repair Device Market - MedCore
- 5. Transcatheter Mitral Valve Repair Device Market - MedCore
- 6. Transcatheter Heart Valve Replacement Market - MedCore
- 7. Cerebral Embolic Protection Device Market - MedCore
- 8. Balloon Valvuloplasty Market - MedCore
- 9. On-Pump Coronary Artery Bypass Device Market - MedCore
- 10. Off-Pump Coronary Artery Bypass Device Market - MedCore
- 11. Autotransfusion Device Market - MedCore
- 12. Endoscopic Vessel Harvesting Device Market - MedCore
- 13. Anastomosis Assist Device (AAD) Market - MedCore
- 14. Transmyocardial Revascularization Market - MedCore
- 15. Ventricular Assist Device (VAD) Market - MedCore
- 16. Intra-Aortic Balloon Pump Market - MedCore
- 17. Artificial Heart Replacement Device Market - MedCore
- 18. Remote Hemodynamic Monitoring System Market - MedCore
- 19. Patent Foramen Ovale Closure Device Market - MedCore
- 20. Patent Ductus Arteriosus Closure Device Market - MedCore
- 21. Atrial Septal & Ventricular Septal Defect Closure Device Marke - MedCore
- 22. Left Atrial Appendage Closure Device Market - MedCore
- 23. Preshaped Guidewire Market - MedCore
- 24. Extracorporeal Membrane Oxygenation Market - MedCore
US Cardiac Surgery Device Market Insights
A major limiter to the cardiac surgery market is the limited clinical data available for some of the newer markets. Growth in the cerebral embolic protection (CEPD) market may be limited until a large randomized clinical trial is conducted to determine the device's exact role in reducing cerebral ischemic volumes. The CEPD market has experienced strong growth in recent years but may be unable to reach its full market potential without this additional clinical data.
A major driver in the cardiac surgery market is the patient population, which is large for many of the indications for cardiac surgery devices. Approximately 1.2 million people in the U.S. have calcified or otherwise damaged aortic valves. This condition is typically present in patients who have several other co-morbidities, making them poor candidates for open, invasive surgery.
Overall, the U.S. cardiac surgery and heart valve device market was valued at $7.2 billion in 2019. This is expected to increase over the forecast period at a CAGR of 7.7% to reach $12.1 billion.
The full report suite on the U.S. market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair devices, transcatheter heart valve replacement devices, cerebral embolic protection devices, balloon valvuloplasty, on-pump coronary artery bypass devices, off-pump coronary artery bypass devices, autotransfusion devices, endoscopic vessel harvesting devices, anastomosis assist devices, transmyocardial revascularization devices, ventricular assist devices, intra-aortic balloon pumps, artificial heart replacement devices, remote hemodynamic monitoring systems, patent foramen ovale closure devices, patent ductus arteriosus closure devices, atrial septal defect devices, ventricular septal defect devices, left atrial appendage closure devices and preshaped guidewires. Analysis of the U.S. market for extracorporeal membrane oxygenation devices is included as an appendix.
TABLE OF CONTENTS
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
- 2.1 BASIC ANATOMY
- 2.2 DISEASE TREATMENTS & DIAGNOSTICS
- 2.2.1 Coronary Artery Disease
- 2.2.2 Myocardial Infarction
- 2.2.3 Angina Pectoris
- 2.2.4 Heart Valve Disease
- 2.2.5 Congestive Heart Failure
- 2.2.6 Aortic Stenosis
- 2.2.7 Degenerative/Functional Mitral Regurgitation
- 2.3 PATIENT DEMOGRAPHICS
PRODUCT ASSESSMENT
- 3.1 INTRODUCTION
- 3.2 PRODUCT PORTFOLIOS
- 3.2.1 Tissue Heart Valve Device
- 3.2.2 Mechanical Heart Valve Device
- 3.2.3 Annuloplasty Repair Device
- 3.2.4 Transcatheter Mitral Valve Repair Device
- 3.2.5 Transcatheter Heart Valve Replacement Device
- 3.2.6 Cerebral Embolic Protection Device
- 3.2.7 Balloon Valvuloplasty Device
- 3.2.8 On-Pump Coronary Artery Bypass Device
- 3.2.9 Off-Pump Coronary Artery Bypass Device
- 3.2.10 Autotransfusion Device
- 3.2.11 Endoscopic Vessel Harvesting Device
- 3.2.12 Anastomosis Assist Device
- 3.2.13 Transmyocardial Revascularization Device
- 3.2.14 Ventricular Assist Device
- 3.2.15 Intra-Aortic Balloon Pump Device
- 3.2.16 Artificial Heart Replacement Device
- 3.2.17 Remote Hemodynamic Monitoring System Device
- 3.2.18 Patent Foramen Ovale Device
- 3.2.19 Patent Ductus Arteriosus Closure Device
- 3.2.20 Atrial & Ventricular Septal Defect Device
- 3.2.21 Left Atrial Appendage Closure Device
- 3.2.22 Preshaped Guidewires
- 3.3 REGULATORY ISSUES AND RECALLS
- 3.4 CLINICAL TRIALS
- 3.4.1 Abbott
- 3.4.2 CryoLife
- 3.4.3 Edwards LifeSciences
- 3.4.4 Medtronic
IMPACT OF COVID-19 ON U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET
- 4.1 INTRODUCTION
- 4.2 MULTI-SCENARIO ANALYSIS
- 4.2.1.1 Best Case Scenario
- 4.2.1.2 Base Case Scenario
- 4.2.1.3 Worst Case Scenario
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET OVERVIEW
- 5.3 TREND ANALYSIS BY SEGMENT
- 5.4 DRIVERS AND LIMITERS
- 5.4.1 Market Drivers
- 5.4.2 Market Limiters
- 5.5 COMPETITIVE MARKET SHARE ANALYSIS
- 5.6 MERGERS AND ACQUISITIONS
- 5.7 COMPANY PROFILES
- 5.7.1 Abbott
- 5.7.2 Abiomed
- 5.7.3 AtriCure
- 5.7.4 Boston Scientific
- 5.7.5 CryoLife
- 5.7.6 Edwards LifeSciences
- 5.7.7 LivaNova
- 5.7.8 Getinge
- 5.7.9 Medtronic
- 5.7.10 Teleflex
- 5.7.11 Terumo
- 5.8 SWOT ANALYSIS
- 5.8.1 Abbott
- 5.8.2 Abiomed
- 5.8.3 AtriCure
- 5.8.4 Boston Scientific
- 5.8.5 CryoLife
- 5.8.7 Edwards LifeSciences
- 5.8.8 LivaNova
- 5.8.10 Getinge
- 5.8.11 Medtronic
- 5.8.12 Teleflex
- 5.8.13 Terumo
PROCEDURE NUMBERS
- 6.1 INTRODUCTION
- 6.2 CARDIAC SURGERY AND HEART VALVE PROCEDURES
- 6.3 SURGICAL HEART VALVE REPLACEMENT PROCEDURES
- 6.3.1 Tissue Heart Valve Procedures by Valve Type
- 6.3.2 Tissue Heart Valve Procedures by Device Type
- 6.3.3 Tissue Heart Valve Procedures by Tissue Type
- 6.3.4 Mechanical Heart Valve Replacement Procedures by Valve Type
- 6.3.5 Mechanical Heart Valve Replacement Procedures by Tissue Type
- 6.4 ANNULOPLASTY REPAIR PROCEDURES
- 6.4.1 Annuloplasty Repair Procedures by Valve Type
- 6.4.2 Annuloplasty Repair Procedures by Device Type
- 6.5 TRANSCATHETER MITRAL VALVE REPAIR PROCEDURES
- 6.5.1 Transcatheter Mitral Valve Procedures by Approach
- 6.5.2 Transcatheter Mitral Valve Repair Procedures by Disease
- 6.6 TRANSCATHETER HEART VALVE REPLACEMENT PROCEDURES
- 6.6.1 Transcatheter Heart Valve Replacement Procedures by Valve Type
- 6.6.1.1 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Approach
- 6.6.1.2 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Patient Risk Class
- 6.6.1.3 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Embolic Protection
- 6.6.1.4 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Therapy
- 6.6.1.5 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Location
- 6.7 BALLOON VALVULOPLASTY PROCEDURES
- 6.8 CABG PROCEDURES
- 6.8.1 CABG Procedures by Support Type
- 6.8.2 CABG Vessel Harvesting Procedures by Type
- 6.8.3 CABG Procedures by Suture Type
- 6.8.4 CABG Procedures by Approach
- 6.9 TRANSMYOCARDIAL REVASCULARIZATION PROCEDURES
- 6.10 VENTRICULAR ASSIST DEVICE PROCEDURES
- 6.10.1 Ventricular Assist Procedures by Device Type
- 6.10.1.1 Percutaneous Ventricular Assist Procedures by Heart Side
- 6.10.1.2 Percutaneous Ventricular Assist Procedures by Indication
- 6.10.1.3 Implantable Ventricular Assist Procedures by Indication
- 6.10.1.4 Implantable Ventricular Assist Procedures by Area
- 6.10.1.5 External Ventricular Assist Procedures by Device Type
- 6.11 INTRA-AORTIC BALLOON COUNTERPULSATION PROCEDURES
- 6.11.1 Intra-Aortic Balloon Counterpulsation Procedures by Setting
- 6.11.2 Intra-Aortic Balloon Counterpulsation Procedures by Device Type
- 6.12 HEART TRANSPLANT PROCEDURES
- 6.13 REMOTE HEMODYNAMIC MONITORING DEVICE IMPLANTATION PROCEDURES
- 6.14 PATENT FORAMEN OVALE CLOSURE PROCEDURES
- 6.15 PATENT DUCTUS ARTERIOSUS CLOSURE PROCEDURES
- 6.16 SEPTAL DEFECT CLOSURE PROCEDURES
- 6.16.1 Septal Defect Closure Procedures by Anatomy
- 6.17 LEFT ATRIAL APPENDAGE CLOSURE PROCEDURES
- 6.17.1 Left Atrial Appendage Closure Procedures by Type
- 6.17.1.1 Epicardial Device Procedures by Device Type
- 6.17.1.1.1 Epicardial Clip Device Procedures by Approach
TISSUE HEART VALVE MARKET
- 7.1 INTRODUCTION
- 7.2 MARKET OVERVIEW
- 7.2.1 Tissue Heart Valve Market by Device Type
- 7.2.2 Tissue Heart Valve Market by Tissue Type
- 7.3 MARKET ANALYSIS AND FORECAST
- 7.3.1 Total Tissue Heart Valve Market
- 7.3.2 Tissue Heart Valve Market by Device Type
- 7.3.2.1 Stented Tissue Heart Valve Market
- 7.3.2.2 Sutureless/Rapid Deployment Tissue Heart Valve Market
- 7.3.2.3 Stentless Tissue Heart Valve Market
- 7.3.3 Tissue Heart Valve Market by Tissue Type
- 7.3.3.1 Xenograft Tissue Heart Valve Market
- 7.3.3.2 Allograft Tissue Heart Valve Market
- 7.4 DRIVERS AND LIMITERS
- 7.4.1 Market Drivers
- 7.4.2 Market Limiters
- 7.5 COMPETITIVE MARKET SHARE ANALYSIS
MECHANICAL HEART VALVE MARKET
- 8.1 INTRODUCTION
- 8.2 MARKET OVERVIEW
- 8.3 MARKET ANALYSIS AND FORECAST
- 8.3.1 Total Mechanical Heart Valve Market
- 8.3.2 Mechanical Heart Valve without Conduit Market
- 8.3.3 Mechanical Heart Valve with Conduit Market
- 8.4 DRIVERS AND LIMITERS
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
- 8.5 COMPETITIVE MARKET SHARE ANALYSIS
ANNULOPLASTY REPAIR DEVICE MARKET
- 9.1 INTRODUCTION
- 9.2 MARKET OVERVIEW
- 9.3 MARKET ANALYSIS AND FORECAST
- 9.3.1 Total Annuloplasty Repair Device Market
- 9.3.2 Ring Device Market
- 9.3.3 Band Device Market
- 9.4 DRIVERS AND LIMITERS
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
- 9.5 COMPETITIVE MARKET SHARE ANALYSIS
TRANSCATHETER MITRAL VALVE REPAIR DEVICE MARKET
- 10.1 INTRODUCTION
- 10.2 MARKET ANALYSIS AND FORECAST
- 10.3 DRIVERS AND LIMITERS
- 10.3.1 Market Drivers
- 10.3.2 Market Limiters
- 10.4 COMPETITIVE MARKET SHARE ANALYSIS
- 10.4.1 Potential Competitors
TRANSCATHETER HEART VALVE REPLACEMENT DEVICE MARKET
- 11.1 INTRODUCTION
- 11.2 MARKET OVERVIEW
- 11.3 MARKET ANALYSIS AND FORECAST
- 11.3.1 Total Transcatheter Heart Valve Replacement Device Market
- 11.3.2 Transcatheter Aortic Valve Replacement Device Market
- 11.3.3 Transcatheter Pulmonary Valve Replacement Device Market
- 11.4 DRIVERS AND LIMITERS
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
- 11.5 COMPETITIVE MARKET SHARE ANALYSIS
- 11.5.1 Potential Competitors
CEREBRAL EMBOLIC PROTECTION DEVICE MARKET
- 12.1 INTRODUCTION
- 12.2 MARKET ANALYSIS AND FORECAST
- 12.3 DRIVERS AND LIMITERS
- 12.3.1 Market Drivers
- 12.3.2 Market Limiters
- 12.4 COMPETITIVE MARKET SHARE ANALYSIS
比較リスト
